Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Shuji, Fushitani"'
Autor:
Ken Konaka, Kota Moriyama, Takumi Sakurada, Naoto Okada, Masaki Imanishi, Yoshito Zamami, Kazuyoshi Kawazoe, Shuji Fushitani, Keisuke Ishizawa
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 3, Iss 1, Pp 1-8 (2017)
Abstract Background In chemotherapy, the full round of treatment must be completed as scheduled to achieve the strongest therapeutic effect. However, peripheral neuropathy, a severe side effect of the chemotherapeutic agent paclitaxel, can force the
Externí odkaz:
https://doaj.org/article/b7c6b4193009430ab7d57fd15031ec2f
Autor:
Keisuke Ishizawa, Masaki Imanishi, Ken Konaka, Sachiko Mori, Soji Kakiuchi, Tatsuhiko Saito, Takumi Sakurada, Shuji Fushitani
Publikováno v:
Biological and Pharmaceutical Bulletin. 42:1839-1845
Uridine 5'-diphospho-glucuronosyltransferase (UGT), a metabolic enzyme of irinotecan active metabolite, has two genetic polymorphisms (UGT1A1*6 and UGT1A1*28). In UGT1A1 homozygous or heterozygous patients, metabolism is delayed and the risk of devel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e58d601d1891db61888e669ce45a15d
https://doi.org/10.1248/bpb.b19-00357
https://doi.org/10.1248/bpb.b19-00357
Autor:
Ken, Konaka, Takumi, Sakurada, Tatsuhiko, Saito, Sachiko, Mori, Masaki, Imanishi, Soji, Kakiuchi, Shuji, Fushitani, Keisuke, Ishizawa
Publikováno v:
Biologicalpharmaceutical bulletin. 42(11)
Uridine 5'-diphospho-glucuronosyltransferase (UGT), a metabolic enzyme of irinotecan active metabolite, has two genetic polymorphisms (UGT1A1*6 and UGT1A1*28). In UGT1A1 homozygous or heterozygous patients, metabolism is delayed and the risk of devel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a1bd1c488eddbbc1c0b2f8d173c7c31f
https://pubmed.ncbi.nlm.nih.gov/31685767
https://pubmed.ncbi.nlm.nih.gov/31685767
Autor:
Keisuke Ishizawa, Takahiro Shibata, Tamiko Nagao, Shuji Fushitani, Hirofumi Shibata, Kazuyoshi Kawazoe, Tomoko Takagai, Naoto Okada
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 42:400-407
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b3b329bdae1328a23625d1f8bac153b
https://doi.org/10.5649/jjphcs.42.400
https://doi.org/10.5649/jjphcs.42.400
Autor:
Hiroyoshi Watanabe, Shingen Nakamura, Keisuke Ishizawa, Naoto Okada, Kazuhiko Teraoka, Masahiro Abe, Toshimi Nakamura, Shuji Fushitani, Momoyo Azuma, Kazuyoshi Kawazoe
Publikováno v:
Biological & Pharmaceutical Bulletin. 39:295-300
The therapeutic effects of anti-methicillin-resistant Staphylococcus aureus (MRSA) agents, vancomycin (VCM), teicoplanin (TEIC), and arbekacin (ABK), depend on their concentrations in blood. Therefore, therapeutic drug monitoring (TDM) is important w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a4c81c11eab5a8c6c2d8636b2f941de
https://doi.org/10.1248/bpb.b15-00774
https://doi.org/10.1248/bpb.b15-00774
Autor:
Miho Watanabe, Tamiko Nagao, Kazuyoshi Kawazoe, Hirofumi Shibata, Kazuo Minakuchi, Tomoko Takagai, Mami Azuma, Takahiro Shibata, Shuji Fushitani
Publikováno v:
Japanese Journal of Infection Prevention and Control. 29:417-423
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ebebd38052f25ddebabe873af7b92cd0
https://doi.org/10.4058/jsei.29.417
https://doi.org/10.4058/jsei.29.417
Autor:
Shuji Fushitani, Hirohumi Shibata, Kazuhiko Teraoka, Toshimi Nakamura, Hirotaka Nishisako, Kazuyoshi Kawazoe, Kazuo Minakuchi
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 35:360-367
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf9ef8f336d5301197e8526b75249374
https://doi.org/10.5649/jjphcs.35.360
https://doi.org/10.5649/jjphcs.35.360
Autor:
Kota Moriyama, Keisuke Ishizawa, Ken Konaka, Masaki Imanishi, Naoto Okada, Yoshito Zamami, Takumi Sakurada, Shuji Fushitani, Kazuyoshi Kawazoe
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences
Journal of Pharmaceutical Health Care and Sciences, Vol 3, Iss 1, Pp 1-8 (2017)
Journal of Pharmaceutical Health Care and Sciences, Vol 3, Iss 1, Pp 1-8 (2017)
Background In chemotherapy, the full round of treatment must be completed as scheduled to achieve the strongest therapeutic effect. However, peripheral neuropathy, a severe side effect of the chemotherapeutic agent paclitaxel, can force the premature
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4c09a31d59401c06c1aa888a92cacc8
http://repo.lib.tokushima-u.ac.jp/114522
http://repo.lib.tokushima-u.ac.jp/114522
Autor:
Shuji Fushitani, Minoru Irahara, Junji Terao, Kazuyoshi Kawazoe, Aiko Yamauchi, Koichiro Tsuchiya, Hiroaki Yanagawa, Eiji Takeda, Yoshihisa Takaishi, Chiho Sato, Yoshiki Kashiwada
Publikováno v:
Experimental and Therapeutic Medicine. 1:481-483
Here, we report on a Consultation Clinic for Complementary and Alternative Medicine (CAM) which we established at Tokushima University Hospital in July of 2007 with the aim of providing person-to-person information on CAM, though not CAM therapy itse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acf4d8d4dd6957a50dc63eec2187a577
https://doi.org/10.3892/etm_00000075
https://doi.org/10.3892/etm_00000075
Publikováno v:
Japanese Journal of Hospital Pharmacy. 24:49-54
We conducted a one-month hospital pharmacy-internship for all fourth-year undergraduates (80 persons) studying at Tokushima University. The students received training on the dispensing service, the way sterilized-medications are prepared in the manuf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c84b47634ce84d61ace991945f59a00
https://doi.org/10.5649/jjphcs1975.24.49
https://doi.org/10.5649/jjphcs1975.24.49